Toyoyuki Hanazawa

6.2k total citations
157 papers, 4.3k citations indexed

About

Toyoyuki Hanazawa is a scholar working on Molecular Biology, Surgery and Cancer Research. According to data from OpenAlex, Toyoyuki Hanazawa has authored 157 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Molecular Biology, 46 papers in Surgery and 40 papers in Cancer Research. Recurrent topics in Toyoyuki Hanazawa's work include MicroRNA in disease regulation (32 papers), Cancer-related molecular mechanisms research (32 papers) and Allergic Rhinitis and Sensitization (28 papers). Toyoyuki Hanazawa is often cited by papers focused on MicroRNA in disease regulation (32 papers), Cancer-related molecular mechanisms research (32 papers) and Allergic Rhinitis and Sensitization (28 papers). Toyoyuki Hanazawa collaborates with scholars based in Japan, United Kingdom and United States. Toyoyuki Hanazawa's co-authors include Yoshitaka Okamoto, Naohiko Seki, Peter J. Barnes, Naoko Kikkawa, Nijiro Nohata, Hideki Enokida, Sergei A. Kharitonov, Masayuki Nakagawa, Kazuhiro Ito and Takashi Kinoshita and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Toyoyuki Hanazawa

149 papers receiving 4.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Toyoyuki Hanazawa Japan 38 2.1k 1.7k 821 634 610 157 4.3k
Sandip M. Kanse Germany 41 1.6k 0.8× 1.4k 0.8× 706 0.9× 594 0.9× 437 0.7× 145 5.2k
Yasuteru Muragaki Japan 43 3.4k 1.6× 789 0.5× 351 0.4× 750 1.2× 646 1.1× 145 7.0k
Calvin Vary United States 40 2.4k 1.1× 635 0.4× 321 0.4× 491 0.8× 780 1.3× 126 4.5k
Takayuki Shiomi Japan 31 1.5k 0.7× 661 0.4× 356 0.4× 300 0.5× 507 0.8× 64 3.3k
Hideki Tanzawa Japan 41 3.1k 1.5× 1.1k 0.7× 527 0.6× 407 0.6× 687 1.1× 197 5.3k
Nadia Rucci Italy 42 2.7k 1.3× 842 0.5× 413 0.5× 396 0.6× 413 0.7× 107 4.8k
Claire M. Dubois Canada 33 1.7k 0.8× 738 0.4× 366 0.4× 229 0.4× 473 0.8× 83 3.8k
Carine Munaut Belgium 52 2.2k 1.0× 2.2k 1.3× 450 0.5× 462 0.7× 653 1.1× 165 7.4k
Eric Camerer United States 32 1.9k 0.9× 537 0.3× 401 0.5× 409 0.6× 361 0.6× 53 5.1k
Jochen W.U. Fries Germany 27 1.6k 0.8× 670 0.4× 228 0.3× 785 1.2× 302 0.5× 81 3.7k

Countries citing papers authored by Toyoyuki Hanazawa

Since Specialization
Citations

This map shows the geographic impact of Toyoyuki Hanazawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toyoyuki Hanazawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toyoyuki Hanazawa more than expected).

Fields of papers citing papers by Toyoyuki Hanazawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toyoyuki Hanazawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toyoyuki Hanazawa. The network helps show where Toyoyuki Hanazawa may publish in the future.

Co-authorship network of co-authors of Toyoyuki Hanazawa

This figure shows the co-authorship network connecting the top 25 collaborators of Toyoyuki Hanazawa. A scholar is included among the top collaborators of Toyoyuki Hanazawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toyoyuki Hanazawa. Toyoyuki Hanazawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kawase, Katsushige, Shusuke Kawashima, Tatsuya Nishi, et al.. (2025). PI3K/Akt Signaling Pathway Regulates CD155 Expression Involved in Resistance to Cancer Immunotherapy. Cancer Immunology Research. 13(10). 1640–1654. 1 indexed citations
2.
Saito, Kazuki, Masayuki Ota, Koji Takahashi, et al.. (2024). Salivary gland-type cancers: cross-organ demographics of a rare cancer. International Journal of Clinical Oncology. 29(6). 755–763. 2 indexed citations
3.
Yonekura, Syuji, Yoshitaka Okamoto, Fumiya Yamaide, et al.. (2024). Factors contributing to the diagnosis and onset prediction of perennial allergic rhinitis in high-risk children: A sub-analysis of the CHIBA study. Allergology International. 73(3). 436–444. 1 indexed citations
4.
Onodera, Atsushi, Kota Kokubo, Masahiro Kiuchi, et al.. (2023). Pathogenic helper T cells as the novel therapeutic targets for immune-mediated intractable diseases. Pharmacology & Therapeutics. 247. 108445–108445. 5 indexed citations
5.
Okano, Susumu, Makoto Tahara, Yoshinori Imamura, et al.. (2023). Darolutamide for patients with androgen receptor positive salivary gland cancers (DISCOVARY): The results of phase 2 study of darolutamide monotherapy.. Journal of Clinical Oncology. 41(16_suppl). 6093–6093. 2 indexed citations
6.
Fukumoto, Ichiro, et al.. (2023). Preoperative simulation using three‐dimensional printer in four temporal bone surgeries. SHILAP Revista de lepidopterología. 11(5). e7135–e7135. 1 indexed citations
7.
Kumagai, Jin, Masahiro Kiuchi, Kota Kokubo, et al.. (2023). The USP7-STAT3-granzyme-Par-1 axis regulates allergic inflammation by promoting differentiation of IL-5-producing Th2 cells. Proceedings of the National Academy of Sciences. 120(49). e2302903120–e2302903120. 12 indexed citations
8.
Arai, Makoto, Mitsuhiro Abe, Izumi Ohno, et al.. (2023). Sequential administration of PD‑1 inhibitor and cetuximab causes pneumonia. Oncology Letters. 26(1). 288–288. 1 indexed citations
9.
Yonekura, Syuji, et al.. (2022). A Case of Methotrexate-Associated Lymphoproliferative Disorder That Required to be Differentiated from Parotid Gland Cancer. Practica Oto-Rhino-Laryngologica. 115(4). 323–331.
10.
Kinoshita, Takashi, Naoko Kikkawa, Keiichi Koshizuka, et al.. (2021). Impact of Oncogenic Targets by Tumor-Suppressive miR-139-5p and miR-139-3p Regulation in Head and Neck Squamous Cell Carcinoma. International Journal of Molecular Sciences. 22(18). 9947–9947. 10 indexed citations
11.
Sakurai, Daiju, Toshioki Sakurai, Syuji Yonekura, et al.. (2019). Sublingual administration of liposomes enclosing alpha-galactosylceramide as an effective adjuvant of allergen immunotherapy in a murine model of allergic rhinitis. Allergology International. 68(3). 352–362. 14 indexed citations
12.
Hanazawa, Toyoyuki, Kazuki Yamasaki, Hideaki Chazono, & Yoshitaka Okamoto. (2017). Endoscopic contralateral transmaxillary approach for pterygoid process osteotomy in total maxillectomy: A technical case report. Auris Nasus Larynx. 45(3). 622–625. 6 indexed citations
13.
Koshizuka, Keiichi, Toyoyuki Hanazawa, Ichiro Fukumoto, et al.. (2016). The microRNA signatures: aberrantly expressed microRNAs in head and neck squamous cell carcinoma. Journal of Human Genetics. 62(1). 3–13. 40 indexed citations
14.
Kinoshita, Takashi, Nijiro Nohata, Toyoyuki Hanazawa, et al.. (2013). Tumour-suppressive microRNA-29s inhibit cancer cell migration and invasion by targeting laminin–integrin signalling in head and neck squamous cell carcinoma. British Journal of Cancer. 109(10). 2636–2645. 111 indexed citations
15.
Hanazawa, Toyoyuki, et al.. (2011). Clinical Study of Multiple Primary Cancer in Patients with Oral and Oropharyngeal Cancer. Nihon Kikan Shokudoka Gakkai Kaiho. 62(2). 150–156. 1 indexed citations
16.
Okamoto, Yoshitaka, Syuji Yonekura, Hideaki Chazono, et al.. (2010). Reevaluation of pollen quantitation by an automatic pollen counter. Allergy and Asthma Proceedings. 31(5). 422–427. 6 indexed citations
17.
Isobe, Koichi, Takashi Uno, Takashi Aruga, et al.. (2005). Weekly cisplatin administration concurrent with radiation therapy for locoregionally advanced nasopharyngeal carcinoma. International Journal of Clinical Oncology. 10(3). 201–203. 3 indexed citations
18.
Tomita, Katsuyuki, Gaetano Caramori, Sam Lim, et al.. (2002). Increased p21CIP1/WAF1 and B Cell Lymphoma Leukemia-xL Expression and Reduced Apoptosis in Alveolar Macrophages from Smokers. American Journal of Respiratory and Critical Care Medicine. 166(5). 724–731. 98 indexed citations
19.
Hanazawa, Toyoyuki, Sergei A. Kharitonov, & Peter J. Barnes. (2000). Increased Nitrotyrosine in Exhaled Breath Condensate of Patients with Asthma. American Journal of Respiratory and Critical Care Medicine. 162(4). 1273–1276. 201 indexed citations
20.
Hanazawa, Toyoyuki, Kōichi Tanaka, Tanemichi Chiba, & Akiyoshi Konno. (1997). Distribution and Origin of Nitric Oxide Synthase-Containing Nerve Fibers in Human Nasal Mucosa. Acta Oto-Laryngologica. 117(5). 735–737. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026